iNtRON Biotechnology Inc
KOSDAQ:048530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
iNtRON Biotechnology Inc
KOSDAQ:048530
|
KR |
|
Q
|
Quanta Services Inc
F:QAA
|
US |
Intrinsic Value
The intrinsic value of iNtRON Biotechnology Inc (048530) under the Base Case is 2 242.09 KRW per share. Compared with the current market price of 2 920 KRW, the stock appears Overvalued by 23% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -138% last year to 9.2% by 2031. Revenue grows about -11% a year over the next five years, after falling about 34% a year over the last five years. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What iNtRON Biotechnology Does
iNtRON Biotechnology Inc. develops and sells molecular diagnostics products and biotech tools. Its business centers on kits, reagents, and related products used to detect pathogens and analyze biological samples, along with some animal-health and research-related offerings. In plain terms, it helps labs and clinics identify disease-causing organisms and perform tests faster and more reliably.
- Headquarters
- Korea KR
- IPO date
- Jan 26, 2011
Revenue & Expenses Breakdown
iNtRON Biotechnology Inc
Earnings Waterfall
iNtRON Biotechnology Inc
The intrinsic value for iNtRON Biotechnology Inc (048530) under the Base Case is 2 242.09 KRW.
Compared with the current market price of 2 920 KRW, the stock appears Overvalued by 23% .